Skip to content

Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery

Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Laparoscopic Gynecology Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05509244
Enrollment
64
Registered
2022-08-22
Start date
2022-09-09
Completion date
2023-08-31
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic Disease

Brief summary

Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative pain and opioid dosages. Investigators are planning to compare the efficacy of 1) acetaminophen only and 2) acetaminophen and ibuprofen combination at postoperative pain after laparoscopic gynecologic surgery.

Detailed description

Acetaminophen and ibuprofen has been safely used for a long time and reduces postoperative pain and opioid dosages. Investigators are planning to compare the efficacy of 1) acetaminophen 1g only and 2) the combination of acetaminophen 1g and ibuprofen 300mg at postoperative pain after laparoscopic gynecologic surgery. Some recovery valuables such as the postoperative pain and opioid requirements will be assessed.

Interventions

DRUGAcetaminophen

acetaminophen 1g iv dripping at end of surgery

DRUGIbuprofen

ibuprofen 300mg iv dripping at end of surgery

Sponsors

The Catholic University of Korea
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled gynecologic laparoscopic surgery

Exclusion criteria

1. Refusal to be enrolled in the study 2. Emergency surgery 3. On chronic pain medications 4. Psychiatric disorders 5. Pregnant, lactating women 6. Allergy or contraindication to the medication drugs

Design outcomes

Primary

MeasureTime frameDescription
postoperative painduring 30 minutes after surgerythe maximal postoperative pain severity using pain scale (0=no pain; 10=the worst pain)

Countries

South Korea

Contacts

Primary Contactyoungeun moon, MD, PhD
0910momo@naver.com822-2258-6163
Backup Contactjungmin gu, MD
cmcanepm@catholic.ac.kr822-2258-6163

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026